Erythropoietin activates SIRT1 to protect human cardiomyocytes against doxorubicin-induced mitochondrial dysfunction and toxicity
- PMID: 28456571
- DOI: 10.1016/j.toxlet.2017.04.018
Erythropoietin activates SIRT1 to protect human cardiomyocytes against doxorubicin-induced mitochondrial dysfunction and toxicity
Abstract
The hormone erythropoietin (EPO) has been demonstrated to protect against chemotherapy drug doxorubicin (DOX)-induced cardiotoxicity, but the underlying mechanism remains obscure. We hypothesized that silent mating type information regulation 2 homolog 1 (SIRT1), an NAD+-dependent protein deacetylase that activates peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), plays a crucial role in regulating mitochondrial function and mediating the beneficial effect of EPO. Our study in human cardiomyocyte AC16 cells showed that DOX-induced cytotoxicity and mitochondrial dysfunction, as manifested by decreased mitochondrial DNA (mtDNA) copy number, mitochondrial membrane potential, and increased mitochondrial superoxide accumulation, can be mitigated by EPO pretreatment. EPO was found to upregulate SIRT1 activity and protein expression to reverse DOX-induced acetylation of PGC-1α and suppression of a suite of PGC-1α-activated genes involved in mitochondrial function and biogenesis, such as nuclear respiratory factor-1 (NRF1), mitochondrial transcription factor A (TFAM), citrate synthase (CS), superoxide dismutase 2 (SOD2), cytochrome c oxidase IV (COXIV), and voltage-dependent anion channel (VDAC). Silencing of SIRT1 via small RNA interference sensitized AC16 cells to DOX-induced cytotoxicity and reduction in mtDNA copy number. Although with SIRT1 silenced, EPO could reverse to some extent DOX-induced mitochondrial superoxide accumulation, loss of mitochondrial membrane potential and ATP depletion, it failed to normalize protein expression of PGC-1α and its downstream genes. Taken together, our results indicated that EPO may activate SIRT1 to enhance mitochondrial function and protect against DOX-induced cardiotoxicity.
Keywords: Cardiotoxicity; Doxorubicin; Erythropoietin; Mitochondrial dysfunction; SIRT1.
Copyright © 2017 Elsevier B.V. All rights reserved.
Similar articles
-
A PGC-1α-Mediated Transcriptional Network Maintains Mitochondrial Redox and Bioenergetic Homeostasis against Doxorubicin-Induced Toxicity in Human Cardiomyocytes: Implementation of TT21C.Toxicol Sci. 2016 Apr;150(2):400-17. doi: 10.1093/toxsci/kfw006. Epub 2016 Jan 18. Toxicol Sci. 2016. PMID: 26781513
-
Cardioprotection against doxorubicin by metallothionein Is associated with preservation of mitochondrial biogenesis involving PGC-1α pathway.Eur J Pharmacol. 2014 Aug 15;737:117-24. doi: 10.1016/j.ejphar.2014.05.017. Epub 2014 May 22. Eur J Pharmacol. 2014. PMID: 24858368
-
Inhibition of miR-23a attenuates doxorubicin-induced mitochondria-dependent cardiomyocyte apoptosis by targeting the PGC-1α/Drp1 pathway.Toxicol Appl Pharmacol. 2019 Apr 15;369:73-81. doi: 10.1016/j.taap.2019.02.016. Epub 2019 Mar 1. Toxicol Appl Pharmacol. 2019. PMID: 30831132
-
Deacetylation of PGC-1α by SIRT1: importance for skeletal muscle function and exercise-induced mitochondrial biogenesis.Appl Physiol Nutr Metab. 2011 Oct;36(5):589-97. doi: 10.1139/h11-070. Epub 2011 Sep 2. Appl Physiol Nutr Metab. 2011. PMID: 21888529 Review.
-
Doxorubicin induced cardio toxicity through sirtuins mediated mitochondrial disruption.Chem Biol Interact. 2022 Sep 25;365:110028. doi: 10.1016/j.cbi.2022.110028. Epub 2022 Jul 31. Chem Biol Interact. 2022. PMID: 35921947 Review.
Cited by
-
Pediatric Cardio-Oncology: Screening, Risk Stratification, and Prevention of Cardiotoxicity Associated with Anthracyclines.Children (Basel). 2024 Jul 22;11(7):884. doi: 10.3390/children11070884. Children (Basel). 2024. PMID: 39062333 Free PMC article. Review.
-
Pharmacological Activation of Rev-erbα Attenuates Doxorubicin-Induced Cardiotoxicity by PGC-1α Signaling Pathway.Cardiovasc Ther. 2023 Feb 22;2023:2108584. doi: 10.1155/2023/2108584. eCollection 2023. Cardiovasc Ther. 2023. PMID: 36874248 Free PMC article.
-
Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer.Curr Neurovasc Res. 2017;14(3):299-304. doi: 10.2174/1567202614666170718092010. Curr Neurovasc Res. 2017. PMID: 28721811 Free PMC article. Review.
-
Resveratrol activation of SIRT1/MFN2 can improve mitochondria function, alleviating doxorubicin-induced myocardial injury.Cancer Innov. 2023 Mar 30;2(4):253-264. doi: 10.1002/cai2.64. eCollection 2023 Aug. Cancer Innov. 2023. PMID: 38089747 Free PMC article.
-
Therapeutic Targets for DOX-Induced Cardiomyopathy: Role of Apoptosis vs. Ferroptosis.Int J Mol Sci. 2022 Jan 26;23(3):1414. doi: 10.3390/ijms23031414. Int J Mol Sci. 2022. PMID: 35163335 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials